Barclays lowered the firm’s price target on Helmerich & Payne to $20 from $24 and keeps an Equal Weight rating on the shares. The company guided to modest pricing and activity declines in North America, the analyst tells investors in a research note. The firm reduced estimates post the earnings report.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HP:
- Helmerich & Payne price target lowered to $25 from $32 at Citi
- Helmerich & Payne’s Earnings Call: Mixed Sentiments and Strategic Moves
- Helmerich & Payne price target lowered to $26 from $28 at TD Cowen
- Helmerich & Payne price target lowered to $25 from $29 at RBC Capital
- Helmerich & Payne Reports Q2 Results, Eyes Growth